IL6 and non-small cell lung carcinoma: Importantly, we discovered a novel mechanism that FXR promotes NSCLC metastasis via binding specifically to the promoters of IL-6ST and IL-6 to increase their transcription and activate the downstream Jak2/STAT3 signaling pathway.